V
主页
2022 WMIF,The Cell Therapy Landscape,CAR-T to Stem Cells
发布人
打开封面
下载高清视频
观看高清视频
视频下载器
2022 WMIF,Cell Therapy and Transplantation for Parkinson'sease
CAR-T Generation for Identity, Purity and Potency Assay Testing
Understanding & predicting outcomes in CAR T-cell therapy
Manufacturing of gene-engineered hematopoietic stem cells
Stem Cell Therapie's Potential in the Pandemic Era
Simplifying GMP CAR T and CAR NK cell therapy manufacturing processes
CAR-T Cell Therapy_ Now and in 2030
Engineering iPSC-derived Natural Killer Cells
Industrialization of Cell Therapy Manufacturing
Off-the-shelf NK cell therapy [WEBINAR]
Removing analytical bottlenecks in cell therapy
Cell therapy logistics_ Exploring the last 100m
A cGMP Compatible, Non-Viral CAR T Cell Manufacturing Process
Utilizing the Gibco CTS Rotea System for cell and gene therapy development
Methods to advance your CAR T & CAR NK cell research
GMP Raw Materials for Cell Therapy - What, When, How?
A CRISPR Vision for the Future of Cell Therapy
All you need for T cell research
Meeting Regulatory Requirements for Cell and Gene Therapy Manufacturing
Addressing the challenges of cell and gene therapy manufacturing
GMP requirements for cell and gene therapy institutions
Keynote_ Carl June | Therapy Gladstone-UCSF
High-Quality Plasmid DNA Manufacturing Strategies for Gene and Cell Therapeutics
Automated, closed manufacturing and sorting of PSCs and their derivatives
Blocking ADAM17 as a therapeutic approach to increase human NK cell proliferatio
Natural Killer (NK) Cells Defenders Against Cancer
How cell and gene therapies can transform the treatment of solid tumours
CAR-T细胞治疗优劣及发展方向
High Cell Density and Perfusion Process Solutions
A Beginner's Guide to Single Cell Sequencing
GMP cell banks as part of a staged, standardized, platform-style cell process
Michel Sadelain - iPSC Derived CAR-Ts Targeting Cancer with an Engineered- iPSC-
Dr. Carl June Presenting at Nobel Conference
2022新型生物药先进技术峰会第四节细胞治疗药物开发技术2k分辨率
Serum-free Expansion of NK Cells with K562- Based Feeder Systems for Clinical Ap
FT596_ iPSC-derived CAR-NK cells with engineered persistence for B-cell malignan
Evaluating expression patterns of multiple inhibitory and stimulatory receptors
CFDI《细胞质量产品GMP指南》解读
实验室记录与数据管理
细胞治疗系列CAR-T疗法在实体瘤治疗中的突破和进展